Skip to main content
SpringerLink
Log in

11C/18F-choline PET or 11C/18F-acetate PET in prostate cancer: may a choice be recommended?

  • Letter to the Editor
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Sarma AV, Schottenfeld D. Prostate cancer incidence, mortality, and survival trends in the United States: 1981–2001. Semin Urol Oncol 2002;20(1):3–9.

    Article  PubMed  Google Scholar 

  2. Beerlage HP, de Reijke TM, de la Rosette JJ. Considerations regarding prostate biopsies. Eur Urol 1998;34(4):303–12.

    Article  PubMed  CAS  Google Scholar 

  3. Djavan B, Zlotta A, Remzi M, Ghawidel K, Basharkhah A, Schulman CC, et al. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men. J Urol 2000;163(4):1144–8, discussion 1148–9.

    Article  PubMed  CAS  Google Scholar 

  4. Sedelaar JP, Vijverberg PL, De Reijke TM, de la Rosette JJ, Kil PJ, Braeckman JG, et al. Transrectal ultrasound in the diagnosis of prostate cancer: state of the art and perspectives. Eur Urol 2001;40(3):275–84.

    Article  PubMed  CAS  Google Scholar 

  5. Briganti A, Chun FK, Salonia A, Zanni G, Scattoni V, Valiquette L, et al. Validation of a nomogram predicting the probability of lymph node invasion among patients undergoing radical prostatectomy and an extended pelvic lymphadenectomy. Eur Urol 2006;49(6):1019–26, discussion 1026–7.

    Article  PubMed  Google Scholar 

  6. Hara T, Kosaka N, Kishi H. PET imaging of prostate cancer using carbon-11-choline. J Nucl Med 1998;39(6):990–5.

    PubMed  CAS  Google Scholar 

  7. Breeuwsma AJ, Pruim J, Jongen MM, Suurmeijer AJ, Vaalburg W, Rien J, et al. In vivo uptake of [11C]choline does not correlate with cell proliferation in human prostate cancer. Eur J Nucl Med Mol Imaging 2005;32:668–73.

    Article  PubMed  Google Scholar 

  8. Picchio M, Messa C, Landoni C, Gianolli L, Sironi S, Brioschi M, et al. Value of [11C]choline-positron emission tomography for re-staging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography. J Urol 2003;169(4):1337–40.

    Article  PubMed  CAS  Google Scholar 

  9. de Jong IJ, Pruim J, Elsinga PH, Vaalburg W, Mensink HJ. 11C-choline positron emission tomography for the evaluation after treatment of localized prostate cancer. Eur Urol 2003;44(1):32–8, discussion 38–9.

    Article  PubMed  Google Scholar 

  10. de Jong IJ, Pruim J, Elsinga PH, Vaalburg W, Mensink HJ. Visualization of prostate cancer with 11C-choline positron emission tomography. Eur Urol 2002;42(1):18–23.

    Article  PubMed  Google Scholar 

  11. de Jong IJ, Pruim J, Elsinga PH, Vaalburg W, Mensink HJ. Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET. J Nucl Med 2003;44(3):331–5.

    PubMed  Google Scholar 

  12. Farsad M, Schiavina R, Castellucci P, Nanni C, Corti B, Martorana G, et al. Detection and localization of prostate cancer: correlation of 11C-choline PET/CT with histopathologic step-section analysis. J Nucl Med 2005;46(10):1642–9.

    PubMed  CAS  Google Scholar 

  13. Reske SN, Blumstein NM, Neumaier B, Gottfried HW, Finsterbusch F, Kocot D, et al. Imaging prostate cancer with 11C-choline PET/CT. J Nucl Med 2006;47(8):1249–54.

    PubMed  CAS  Google Scholar 

  14. Hara T, Kondo T, Hara T, Kosaka N. Use of 18F-choline and 11C-choline as contrast agents in positron emission tomography imaging-guided stereotactic biopsy sampling of gliomas. J Neurosurg 2003;99(3):474–9.

    Article  PubMed  Google Scholar 

  15. Cimitan M, Bortolus R, Morassut S, Canzonieri V, Garbeglio A, Baresic T, et al. [18F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients. Eur J Nucl Med Mol Imaging 2006;33(12):1387–98.

    Article  PubMed  Google Scholar 

  16. Oyama N, Akino H, Kanamaru H, Suzuki Y, Muramoto S, Yonekura Y, et al. 11C-acetate PET imaging of prostate cancer. J Nucl Med 2002;43(2):181–6.

    PubMed  CAS  Google Scholar 

  17. Yoshimoto M, Waki A, Yonekura Y. Characterization of acetate metabolism in tumor cells in relation to cell proliferation: acetate metabolism in tumor cells. Nucl Med Biol 2001;28:117–22.

    Article  PubMed  CAS  Google Scholar 

  18. Kotzerke J, Volkmer BG, Glatting G, van den Hoff J, Gschwend JE, Messer P, et al. Intraindividual comparison of [11C]acetate and [11C]choline PET for detection of metastases of prostate cancer. Nuklearmedizin 2003;42(1):25–30.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nuclear Medicine Department, Policlinico S. Orsola-Malpighi, Bologna University, Bologna, Italy

    Cristina Nanni, Paolo Castellucci, Mohsen Farsad & Stefano Fanti

  2. Nuclear Medicine, PET Unit, S. Maria della Misericordia Rovigo Hospital, Istituto Oncologico Veneto (IOV)-IRCCS, Viale Tre Martiri, 140, 45100, Rovigo, Italy

    Domenico Rubello

Authors
  1. Cristina Nanni
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paolo Castellucci
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mohsen Farsad
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Domenico Rubello
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Stefano Fanti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Domenico Rubello.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nanni, C., Castellucci, P., Farsad, M. et al. 11C/18F-choline PET or 11C/18F-acetate PET in prostate cancer: may a choice be recommended?. Eur J Nucl Med Mol Imaging 34, 1704–1705 (2007). https://doi.org/10.1007/s00259-007-0491-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-007-0491-5

Keywords

Search

Navigation